Brassica napus (Rutabaga)
Rutabaga (Brassica napus) is a cruciferous vegetable rich in glucosinolates, particularly gluconapin and glucobrassicanapin, which are hydrolyzed by myrosinase into bioactive isothiocyanates. These compounds modulate antioxidant enzymes and inflammatory pathways, underpinning rutabaga's preliminary anti-inflammatory and free radical scavenging properties.

Origin & History
Rutabaga (Brassica napus var. napobrassica) is a root vegetable originating from a 17th-century hybrid cross between turnip and cabbage. Cultivated widely in Northern Europe and North America, its edible roots, leaves, and seeds are characterized by a pungent flavor due to glucosinolates and phenolic compounds. For research, its bioactive compounds are typically extracted from seeds using various solvents.
Historical & Cultural Context
Since the 17th century, rutabaga has been a staple food in Europe and North America, commonly mashed (rotmos) or used as livestock forage. It also has a cultural history in the British Isles, where it was traditionally carved into Jack-o'-lanterns for Halloween. No documented use in traditional medicine systems was found in the research.
Health Benefits
["\u2022 Antioxidant Activity (Preliminary Evidence): In an in vitro study, a methanol extract of rutabaga seeds demonstrated 52.95% DPPH free radical scavenging activity at a concentration of 50 \u00b5g/mL (PMID: 37687079).", "\u2022 Anti-Inflammatory Potential (Preliminary Evidence): In a lab setting, non-polar extracts from rutabaga seeds showed moderate anti-inflammatory effects, inhibiting the 15-lipoxygenase (15-LOX) enzyme by less than 30% (PMID: 37687079).", "\u2022 Cellular Safety Profile (Preliminary Evidence): In one in vitro study, rutabaga seed extracts showed no cytotoxicity against normal human kidney cells (HEK-293), suggesting a good safety profile at the cellular level (PMID: 37687079).", "\u2022 Limited Anti-Cancer Cell Activity (Preliminary Evidence): Research is limited to a single in vitro study where seed extracts exhibited limited anti-proliferative effects against Caco-2 colon cancer cells (PMID: 37687079).", "\u2022 Rich Source of Phenolic Compounds (Analytical Evidence): Rutabaga seeds, sprouts, and roots contain a range of polyphenols (5.1\u2013125.7 mg GAE/g), including gallic acid, p-coumaric acid, and trans-ferulic acid, which are known for their bioactive properties."]
How It Works
Glucosinolates in rutabaga are enzymatically converted by myrosinase to isothiocyanates such as allyl isothiocyanate, which activate the Nrf2/Keap1 transcription pathway, upregulating cytoprotective enzymes including heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1). These isothiocyanates also suppress NF-κB signaling, reducing downstream production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Additionally, phenolic compounds including hydroxycinnamic acid derivatives present in rutabaga directly scavenge reactive oxygen species (ROS), contributing to DPPH radical neutralization observed in vitro.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses on rutabaga as a biomedical supplement were found in the available research. Current scientific understanding is based solely on preliminary in vitro (test-tube) studies, such as one investigating the antioxidant and anti-proliferative potential of seed extracts (PMID: 37687079).
Clinical Summary
Evidence for rutabaga's health effects remains at the preliminary, in vitro stage with no large-scale human clinical trials published to date. One in vitro study (PMID: 37687079) demonstrated that a methanol seed extract achieved 52.95% DPPH free radical scavenging activity at 50 µg/mL, suggesting meaningful antioxidant capacity under laboratory conditions. Anti-inflammatory properties have been observed in cell-based assays, though translation to human physiology requires controlled clinical investigation. The overall evidence base is insufficient to establish therapeutic dosing recommendations, and rutabaga's benefits are best understood through its nutritional profile rather than supplemental use.
Nutritional Profile
Rutabaga (Brassica napus) per 100g raw: Calories ~37 kcal, Carbohydrates ~8.6g (of which sugars ~6.0g), Dietary Fiber ~2.3g (mix of soluble pectin and insoluble cellulose/hemicellulose), Protein ~1.1g (relatively low, incomplete amino acid profile), Fat ~0.2g. Key Vitamins: Vitamin C ~25mg (~28% DV; moderate bioavailability, heat-sensitive, significantly reduced by boiling), Vitamin K1 ~0.3µg, Folate (B9) ~21µg (~5% DV), Vitamin B6 ~0.1mg, Thiamine (B1) ~0.09mg, small amounts of Vitamin E (~0.3mg). Key Minerals: Potassium ~305mg (~9% DV; good bioavailability), Calcium ~47mg (~5% DV; bioavailability partially limited by oxalates), Magnesium ~20mg, Phosphorus ~53mg, Manganese ~0.13mg, small amounts of Iron (~0.44mg, non-heme, lower bioavailability). Bioactive Compounds: Glucosinolates (notably gluconapin and progoitrin, ~1–3 µmol/g fresh weight; converted to isothiocyanates and nitriles upon hydrolysis by myrosinase enzyme, relevant to antioxidant and potential anticancer activity; cooking inactivates myrosinase reducing conversion efficiency), Carotenoids (~beta-carotene ~10µg, lutein/zeaxanthin trace amounts), Polyphenols including hydroxycinnamic acids (sinapic acid derivatives) and flavonoids (quercetin glycosides) at modest concentrations. Anthocyanins present in purple-skinned varieties. Indole-3-carbinol may be generated from glucosinolate breakdown. Fiber bioavailability note: pectin fraction contributes to viscosity in the gut, supporting cholesterol modulation. Glucosinolate bioavailability is higher in raw consumption; boiling leaches water-soluble glucosinolates and Vitamin C by 20–40%.
Preparation & Dosage
No clinically studied dosage for rutabaga supplements has been established, as no human trials have been conducted. In vitro research has used seed extracts at concentrations of 50 µg/mL, but this does not translate to a human dose. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Iodine, Gallic Acid, Turnip, Cabbage
Safety & Interactions
Rutabaga consumed as a whole food is generally recognized as safe for most adults, but high intake may cause gastrointestinal bloating, gas, and flatulence due to its raffinose-type oligosaccharides and fiber content. Individuals taking anticoagulant medications such as warfarin should exercise caution, as rutabaga's vitamin K content may interfere with INR stability. Due to its goitrogenic glucosinolate content, individuals with hypothyroidism or iodine deficiency should avoid excessive consumption, as glucosinolates can inhibit thyroid iodine uptake when eaten raw in large quantities. Pregnant and breastfeeding women may consume rutabaga as a food safely, but concentrated rutabaga seed extracts or supplements lack adequate safety data for these populations.